Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-22
2009-10-13
Shiao, Rei-Tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S422000, C514S423000, C546S276400, C548S518000, C548S530000
Reexamination Certificate
active
07601742
ABSTRACT:
The present invention relates to inhibition of viruses, e.g., HIV using pyrrolidones and compounds related to pyrrolidones. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions that inhibit HIV in a cell; as well as to methods of prophylaxis, and therapy related to HIV infection and related disease states such as AIDS.
REFERENCES:
patent: 4012495 (1977-03-01), Schmiechen et al.
patent: 4193926 (1980-03-01), Schmiechen et al.
patent: 5547979 (1996-08-01), Christensen, IV et al.
patent: 5783591 (1998-07-01), Klose et al.
patent: 5998453 (1999-12-01), Klose et al.
patent: WO 93/07141 (1993-04-01), None
patent: WO 03/032981 (2003-04-01), None
Keller, Thomas H. et al, “Synthesis and Structure-Activity Relationship of N-Arylrolipram Derivatives as Inhibitors of PDE4 Isozymes,” Chem. Pharm. Bull. 2001 pp. 1009-1017, vol. 49(8).
Bacher, Edmond et al., “N-Arylrolipram Derivatives as Potent and Selective PDE4 Inhibitors”,Bioorganic&Med. Chem. Letters, 1998, pp. 3229-3234, vol. 8.
Keller, Thomas H., et al., “Synthesis and Structure-Activity Relationship of N-Arylrolipram Derivatives as Inhibitors of PDE4 Isozymes”,Chem. Pharm. Bull, 2001, pp. 1009-1017, vol. 49(8).
Huff, et al., “HIV Protease: A Novel Chemotherapeutic Target for AIDS”,J. Med. Chem., vol. 34(8) 1991, pp. 2305-2314.
Menendez-Arias, Luis, “Targeting HIV: antiretroviral therapy and development of drug resistance”,Trends in Pharmaceutical Sciences, vol. 23(8), Aug. 2002.
Aebischer, et al., “Synthesis ofN-Arylrolipram Derivatives—Potent and Selective Phosphodiesterase-IV Inhibitors—By Copper Catalyzed Lactam-Aryl Halide Coupling”,Heterocyles, vol. 48, No. 11, pp. 2225-2229, 1998.
Bursulaya Badry
Ellis David Archer
He Xiaohui
He Yun
Jiang Tao
Coppins Janet L
Genomics Institute of the Novartis Research Foundation
IRM LLC
Shiao Rei-Tsang
Tongco Wu Emily
LandOfFree
Pyrrolidones with anti-HIV activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolidones with anti-HIV activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidones with anti-HIV activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4121203